Martins, FilipeObeid, Michel2020-06-272020-06-272020-06-272020-06-1610.1038/s41571-020-0400-4https://infoscience.epfl.ch/handle/20.500.14299/169652WOS:000540679900001OncologyOncologyPersonalized treatment of immune-related adverse events - balance is requiredtext::journal::journal article::research article